-
Antifibrinolytic Drugs Market to Hit $19.3 Billion by 2026 Amid Rising Demand for Hemorrhage Control
10 Jul 2025 06:14 GMT
… .,
Sanofi S.A.,
Takeda Pharmaceutical Company Limited,
Vitruvias Therapeutics Inc … with clotting factor replacement to treat hemophilia. These prevent the … of hypertension throughout the globe. Furthermore, the global antifibrinolytic drugs market …
-
Patients, caregivers groan as drug prices soar despite tariff waiver
10 Jul 2025 05:25 GMT
… duty on pharmaceuticals and active pharmaceutical ingredients (APIs … pack, while injectable medications such as Rocephin … as asthma, diabetes, hypertension, arthritis, and heart … providers, worsening drug resistance, treatment failure, and mortality …
-
Lorundrostat Significantly Lowers Blood Pressure in Uncontrolled and Resistant Hypertension: Launch-HTN Trial
10 Jul 2025 08:08 GMT
… . Lorundrostat, a new oral medication that inhibits aldosterone synthesis, was … were classified as having treatment-resistant hypertension. The trial used a 1:2 … weeks due to FDA guidance for placebo-controlled hypertension trials. Additionally, …
-
Get Patients to Take Their BP Meds? Intervention Falls Short
10 Jul 2025 08:10 GMT
… hypertension whose electronic health record indicated they were not taking their medications … uncontrolled hypertension and low medication adherence in a cluster randomized trial. … is guideline recommended for hypertension, we found potential limitations …
-
People With Chronic Kidney Disease Have a Weaker Sense of Saltiness. Adding Sweetness Seems To Compound the Problem. That Makes It Harder To Control Hypertension.
10 Jul 2025 04:29 GMT
We love salt. So does the rest of the planet. Excess sodium consumption is associated with nearly 2 million deaths a year, according to the World Health Organization, from medical conditions ranging from cardiovascular disease to obesity, osteoporosis, …
-
STAT+: Pharmalittle: We’re reading about Trump’s latest tariff threat, a Merck deal, and lots more
10 Jul 2025 02:22 GMT
… most significant comment on pharmaceutical tariffs since April, … its blockbuster cancer drug Keytruda loses patent protection … is Ohtuvayre, a treatment for chronic obstructive pulmonary … a medicine to treat pulmonary arterial hypertension, that it acquired …
-
Popular Weight Loss Drugs May Help Treat Migraines Too, Study Finds
09 Jul 2025 21:43 GMT
… medications like Ozempic and Mounjaro show potential for treating … 1 currently used to treat type 2 diabetes, … people with idiopathic intracranial hypertension, a condition that causes … treatments.
GLP-1 drugs are not yet approved by the Food and Drug …
-
Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma
09 Jul 2025 20:22 GMT
… in prescribers of the medication compared to the fourth … assets or drugs in late-stage development with the … drug that received FDA approval last year for treating pulmonary arterial hypertension. … pipeline and portfolio of treatments for cardio-pulmonary …
-
Report non-compliant pharmacies on VAT-exempt medicines – BIR
09 Jul 2025 18:34 GMT
… the Food and Drug Administration (FDA) and the Department … to make essential medical treatment affordable to all. … , 19 drugs used to treat cancer, diabetes, hypertension, high cholesterol … pharmaceutical companies and retailers, in coordination with the FDA, …
-
Guangdong Zhongsheng Ruichuang Pharmaceutical discovers new GLP-1R agonists
09 Jul 2025 16:47 GMT
… /metabolic
Guangdong Zhongsheng Ruichuang Pharmaceutical Co. Ltd. has described glucagon … to be useful for the treatment of type 2 diabetes, obesity … /MASH), hyperglycemia, cerebral infarction, hypertension and Parkinson’s disease.
BioWorld …